Search Browse Earnings

Evoke Pharma Inc

Nasdaq:EVOK

Pharmaceutical Preparations·SOLANA BEACH, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Evoke Pharma Inc — SlamSEC

Revenue

$5.2M

+106.5% YoY

FY 2024

Adj. EBITDA

—

Net Income

-$5.4M

-103.3% margin

FY 2024

EPS (Diluted)

-$27.97

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$4.7M

FY 2024

Total Debt

$9.2M

FY 2016

Net Debt

$4.5M

FY 2016

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—